The Chase Group is proud to announce the completion of the Chief Medical Officer search with Akcea Therapeutics. The CMO will provide innovative and visionary leadership to develop clinical and medical strategy for a pipeline that has the potential to change the approach to treating cardiometabolic lipid disorders. To learn more about The Chase Group’s strength in securing senior leadership talent, contact us at chase@chasegroup.com.
The Chase Group completes CMO search with Akcea Therapeutics
The Chase Group is proud to announce the completion of the Chief Medical Officer search with Akcea Therapeutics. The CMO will provide innovative and visionary leadership to develop clinical and medical strategy for a pipeline that has the potential to change the approach to treating cardiometabolic lipid disorders. To learn more about The Chase Group’s strength in securing senior leadership talent, contact us at chase@chasegroup.com.- Categories: Pharmaceutical
Aeglea BioTherapeutics Builds Rare Disease Clinical Development Team Through Partnership with The Chase Group, Inc.
Through our ongoing partnership, Aeglea Biotherapeutics has secured a Vice President, Clinical Development, Rare Disease. The new Vice President will play a crucial role in…
Eli Lilly Welcomes New Vice President, Immuno-Oncology Global & US Medical Affairs
The Chase Group is pleased to announce the placement of the Vice President, Immuno-Oncology Global & US Medical Affairs for Eli Lilly. The successful candidate…
The Chase Group Places VP of Clinical Development and Pharmacovigilance at Marinus Pharmaceuticals
The Chase Group is pleased to continue partnership with Marinus in building their leadership team with the recent placement of the Vice President of Clinical…-
The Chase Group Secures the Vice President, US and Global Medical Affairs for Eli Lilly
The Chase Group is pleased to announce the successful completion of the Vice President, US and Global Medical Affairs at Eli Lilly. The new Vice… 
Ionis Pharmaceuticals Secures Associate Director, Investor Relations
The Chase Group is pleased to announce our latest placement for Ionis Pharmaceuticals. Due to exciting organizational growth, Ionis welcomes a new Associate Director, Investor…
The Chase Group Secures the Vice President, Global Head of Data Sciences for Genmab
The Chase Group is pleased to announce the successful completion of the Vice President, Global Head of Data Sciences search at Genmab. A scientist with…